Suzanne E. Schindler
@suzanneeschindler
Clinical neurologist and neuroscientist dedicated to improving the diagnosis and treatment of dementia.
🚀 Dynamic plots of Alzheimer's disease biomarker relationships! 🧠 alz-journals.onlinelibrary.wiley.com/doi/10.1002/... 🌧️ Rain drops (amyloid.shinyapps.io/ADNI_Raindro...): Relationships between the baseline rank of one biomarker and the interpolated value of a second biomarker over time.
🚀 Dynamic plots of Alzheimer's disease biomarker relationships! 🧠 alz-journals.onlinelibrary.wiley.com/doi/10.1002/... 🏹 Time trails (amyloid.shinyapps.io/ADNI_Time_Tr...): Relationships between two biomarkers are interpolated over time.
⏱️ What is the “door-to-needle” time for amyloid-targeting treatments? 🧠 A new paper led by Anna Hofmann from the Washington University Memory Diagnostic Center examined this in a real-world memory clinic setting. alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
🩸 🧠 ⏱️ What if a blood test could predict WHEN an individual would develop symptoms of Alzheimer’s disease? High plasma p-tau217 predicts greater risk for Alzheimer’s symptoms—do the plasma p-tau217 levels provide insights into WHEN symptoms might begin? nature.com/articles/s41...
We have been trying to learn everything we can from our experiences with amyloid-targeting treatments to improve patient care. We present the findings from our first 234 patients treated with lecanemab in JAMA Neurology: ja.ma/42TLKzx #ENDALZ @WashUNeurology